Wazir, N. and Rehman, S.U. 2022. Efficacy and Safety of Empagliflozin as Add-On Therapy in Patients of Type-2 Diabetes Mellitus. Journal of Gandhara Medical and Dental Science. 9, 1 (Jan. 2022), 24–27. DOI:https://doi.org/10.37762/jgmds.9-1.173.